Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice - PubMed (original) (raw)

Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice

Valerie Blanc et al. Cancer Res. 2007.

Abstract

The RNA-specific cytidine deaminase apobec-1 is an AU-rich RNA binding protein that binds the 3' untranslated region (UTR) of cyclooxygenase-2 (Cox-2) mRNA and stabilizes its turnover in vitro. Cox-2 overexpression accompanies intestinal adenoma formation in both humans and mice. Evidence from both genetic deletion studies as well as from pharmacologic inhibition has implicated Cox-2 in the development of intestinal adenomas in experimental animals and in adenomas and colorectal cancer in humans. Here, we show that small intestinal adenoma formation is dramatically reduced in compound Apc(min/+) apobec-1(-/-) mice when compared with the parental Apc(min/+) strain. This reduced tumor burden was found in association with increased small intestinal apoptosis and reduced proliferation in small intestinal crypt-villus units from compound Apc(min/+) apobec-1(-/-) mice. Intestinal adenomas from compound Apc(min/+) apobec-1(-/-) mice showed a <2-fold increase in Cox-2 mRNA abundance and reduced prostaglandin E(2) content compared with adenomas from the parental Apc(min/+) strain. In addition, there was reduced expression in adenomas from compound Apc(min/+) apobec-1(-/-) mice of other mRNAs (including epidermal growth factor receptor, peroxisome proliferator-activated receptor delta, prostaglandin receptor EP4, and c-myc), each containing the apobec-1 consensus binding site within their 3'-UTR. Adenovirus-mediated apobec-1 introduction into HCA-7 (colorectal cancer) cells showed a dose-dependent increase in Cox-2 protein and stabilization of endogenous Cox-2 mRNA. These findings suggest that deletion of apobec-1, by modulating expression of AU-rich RNA targets, provides an important mechanism for attenuating a dominant genetic restriction point in intestinal adenoma formation.

PubMed Disclaimer

Cited by

Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination.
Pecori R, Di Giorgio S, Paulo Lorenzo J, Nina Papavasiliou F. Pecori R, et al. Nat Rev Genet. 2022 Aug;23(8):505-518. doi: 10.1038/s41576-022-00459-8. Epub 2022 Mar 7. Nat Rev Genet. 2022. PMID: 35256818 Free PMC article. Review.
Activation-induced cytidine deaminase is a possible regulator of cross-talk between oocytes and granulosa cells through GDF-9 and SCF feedback system.
Iizuka T, Wakae K, Ono M, Suzuki T, Mizumoto Y, Kitamura K, Horike SI, Muramatsu M, Fujiwara H. Iizuka T, et al. Sci Rep. 2021 Feb 15;11(1):3833. doi: 10.1038/s41598-021-83529-x. Sci Rep. 2021. PMID: 33589683 Free PMC article.
A mark of disease: how mRNA modifications shape genetic and acquired pathologies.
Destefanis E, Avşar G, Groza P, Romitelli A, Torrini S, Pir P, Conticello SG, Aguilo F, Dassi E. Destefanis E, et al. RNA. 2021 Apr;27(4):367-389. doi: 10.1261/rna.077271.120. Epub 2020 Dec 29. RNA. 2021. PMID: 33376192 Free PMC article. Review.
Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
Caval V, Jiao W, Berry N, Khalfi P, Pitré E, Thiers V, Vartanian JP, Wain-Hobson S, Suspène R. Caval V, et al. BMC Genomics. 2019 Nov 14;20(1):858. doi: 10.1186/s12864-019-6216-x. BMC Genomics. 2019. PMID: 31726973 Free PMC article.
Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer.
Makkar S, Riehl TE, Chen B, Yan Y, Alvarado DM, Ciorba MA, Stenson WF. Makkar S, et al. Mol Cancer Ther. 2019 Dec;18(12):2446-2456. doi: 10.1158/1535-7163.MCT-18-1225. Epub 2019 Sep 4. Mol Cancer Ther. 2019. PMID: 31484704 Free PMC article.

Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice - PubMed (original) (raw)